Patients With Larger Left Atrial Appendage Orifice Presented Worse Prognosis Contributed by Acute Heart Failure After

Zhongyuan Ren1, Yixing Zheng1, Jingying Zhang1

  • 1Heart Center, Shanghai Tenth People's Hospital, School of Medicine Tongji University Shanghai China.

Insights

Left atrial appendage closure (LAAC) for atrial fibrillation patients with larger LAA orifices shows a worse prognosis, including increased acute heart failure risk. Larger LAA size predicts adverse events, except in specific patient subgroups.

Area of Science:

  • Cardiology
  • Medical Devices
  • Clinical Outcomes

Background:

  • Left atrial appendage closure (LAAC) prevents stroke in atrial fibrillation but may compromise left atrial compliance and patient prognosis.
  • The impact of left atrial appendage (LAA) orifice size on post-LAAC outcomes requires further investigation.

Purpose of the Study:

  • To comparatively evaluate the prognosis of LAAC in patients stratified by LAA orifice size.
  • To identify LAA orifice size as a predictor of adverse clinical events following LAAC.

Main Methods:

  • 302 patients undergoing successful LAAC were categorized into four groups based on LAA orifice size measured by transesophageal echocardiography.
  • Clinical outcomes including thromboembolic events, major cardiocerebrovascular adverse events, and acute heart failure (AHF) were analyzed.
  • Propensity-score matching was used to compare outcomes between large and small LAA orifice groups.

Main Results:

  • Thromboembolic event survival was similar across groups.
  • The largest LAA orifice group exhibited significantly lower survival for major cardiocerebrovascular adverse events (P<0.001), with a higher incidence of AHF (NYHA class III-IV, 21.4%, P=0.009).
  • A large LAA orifice predicted major cardiocerebrovascular adverse events (HR, 3.749), except in younger patients, those with paroxysmal atrial fibrillation, or failed rhythm/rate control.

Conclusions:

  • Larger LAA orifice size is associated with a worse prognosis after LAAC, characterized by increased AHF incidence.
  • LAA orifice size serves as a predictor for post-LAAC AHF events in most patients, with exceptions noted for specific subgroups.

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
35
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
26
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
17